SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem submits annual report

27 Jul 2019 Evaluate

NGL Fine-Chem has informed about submission of the Annual Report containing the Director’s Report and its annexures, Management Discussion and Analysis Report, Corporate Governance Report and Audited Financial Statements along with the Notice of 38th Annual General Meeting of the Company for the financial year ended on 31st March, 2019. 

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

3111.80 48.20 (1.57%)
15-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.45
Dr. Reddys Lab 1279.25
Cipla 1381.50
Zydus Lifesciences 1087.75
Lupin 2273.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: